Download PDF

Other users also viewed these articles

Metabolic dysfunction: The silenced connection with fatty liver disease Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;
Ann Hepatol. 2023;28:
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease Jing Liu; Haifeng Lv; Jie Wang; Qianru Zhu; Gongying Chen; Yanming Jiang; Ke Zhao; Li Shao; Junping Shi; Xiaoben Pan;
Ann Hepatol. 2023;28:
Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience Thanikan Sukaram; Soe Thiha Maung; Yuda Chongpison; Tassanan Jaihan; Chonlada Phathong; Roongruedee Chaiteerakij;
10.1016/j.aohep.2024.101753